{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T17:15:07Z","timestamp":1778087707279,"version":"3.51.4"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Regulatory Toxicology and Pharmacology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.yrtph.2026.106085","type":"journal-article","created":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T08:10:31Z","timestamp":1774599031000},"page":"106085","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["10-step systemic safety assessment of extractables and leachables associated with drug products integrating topline, traditional, and next generation risk assessment"],"prefix":"10.1016","volume":"169","author":[{"given":"Frank","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yrtph.2026.106085_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2021.105094","article-title":"A 10-step framework for use of read-across (RAX) in next generation risk assessment (NGRA) for cosmetics safety assessment","volume":"129","author":"Alexander-White","year":"2022","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2026.106085_bib2","article-title":"Next generation risk assessment for skin sensitization: a case study with propyl paraben","volume":"123","author":"Assaf","year":"2021","journal-title":"Regul. Toxicol. Pharmacol."},{"issue":"1","key":"10.1016\/j.yrtph.2026.106085_bib3","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1093\/toxsci\/kfaa048","article-title":"A next-generation risk assessment case study for coumarin in cosmetic products","volume":"176","author":"Baltazar","year":"2020","journal-title":"Toxicol. Sci."},{"issue":"3","key":"10.1016\/j.yrtph.2026.106085_bib4","first-page":"511","article-title":"Making safety decisions for a sunscreen active ingredient using next-generation risk assessment: benzophenone-4 case study","volume":"42","author":"Baltazar","year":"2025","journal-title":"ALTEX"},{"key":"10.1016\/j.yrtph.2026.106085_bib81","doi-asserted-by":"crossref","first-page":"114916","DOI":"10.1016\/j.fct.2024.114916","article-title":"Human next-generation risk assessment of trichothecene toxicity","volume":"92","author":"Beal","year":"2024","journal-title":"Food Chem Toxicol"},{"issue":"3","key":"10.1016\/j.yrtph.2026.106085_bib5","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.yrtph.2015.01.008","article-title":"An exposure:activity profiling method for interpreting high-throughput screening data for estrogenic activity--proof of concept","volume":"71","author":"Becker","year":"2015","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2026.106085_bib6","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.comtox.2017.10.001","article-title":"Ab initio chemical safety assessment: a workflow based on exposure considerations and non-animal methods","volume":"4","author":"Berggren","year":"2017","journal-title":"Comput. Toxicol."},{"issue":"1","key":"10.1016\/j.yrtph.2026.106085_bib79","first-page":"167","article-title":"The long way from raw data to NAM-based information: Overview on data layers and processing steps","volume":"42","author":"Blum","year":"2025","journal-title":"ALTEX"},{"issue":"9","key":"10.1016\/j.yrtph.2026.106085_bib84","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1038\/nprot.2016.105","article-title":"Cell Painting, a high-content image-based assay for morphological profiling using multiplexed fluorescent dyes","volume":"11","author":"Bray","year":"2016","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.yrtph.2026.106085_bib7","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.yrtph.2016.08.011","article-title":"Assessing safety of extractables from materials and leachables in pharmaceuticals and biologics - current challenges and approaches","volume":"81","author":"Broschard","year":"2016","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2026.106085_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2021.104931","article-title":"New framework for a non-animal approach adequately assures the safety of cosmetic ingredients - a case study on caffeine","volume":"123","author":"Bury","year":"2021","journal-title":"Regul. Toxicol. Pharmacol."},{"issue":"1","key":"10.1016\/j.yrtph.2026.106085_bib10","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1093\/toxsci\/kfae159","article-title":"Advancing systemic toxicity risk assessment: evaluation of a NAM-based toolbox approach","volume":"204","author":"Cable","year":"2025","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.yrtph.2026.106085_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.tiv.2021.105090","article-title":"Exploring in vitro to in vivo extrapolation for exposure and health impacts of e-cigarette flavor mixtures","volume":"72","author":"Chang","year":"2021","journal-title":"Toxicol. Vitro"},{"issue":"3","key":"10.1016\/j.yrtph.2026.106085_bib12","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/s41596-022-00754-y","article-title":"Measuring DNA modifications with the comet assay: a compendium of protocols","volume":"18","author":"Collins","year":"2023","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.yrtph.2026.106085_bib14","article-title":"Next-generation risk assessment: integrating in vitro data and physiologically-based pharmacokinetic (PBPK) modeling for vancomycin nephrotoxicity evaluation","volume":"1","author":"da Silva","year":"2025","journal-title":"NAM J."},{"key":"10.1016\/j.yrtph.2026.106085_bib15","article-title":"Innovative tools and methods for toxicity testing within PARC work package 5 on hazard assessment","volume":"5","author":"De","year":"2023","journal-title":"Front. Toxicol."},{"key":"10.1016\/j.yrtph.2026.106085_bib16","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.comtox.2018.06.001","article-title":"Principles underpinning the use of new methodologies in the risk assessment of cosmetic ingredients","volume":"7","author":"Dent","year":"2018","journal-title":"Comput. Toxicol."},{"issue":"2","key":"10.1016\/j.yrtph.2026.106085_bib17","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1093\/toxsci\/kfy245","article-title":"Employing dietary comparators to perform risk assessments for anti-androgens without using animal data","volume":"167","author":"Dent","year":"2019","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.yrtph.2026.106085_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2021.105026","article-title":"Paving the way for application of next generation risk assessment to safety decision-making for cosmetic ingredients","volume":"125","author":"Dent","year":"2021","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2026.106085_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1345992","article-title":"Next generation risk assessment: an ab initio case study to assess the systemic safety of the cosmetic ingredient, benzyl salicylate, after dermal exposure","volume":"15","author":"Ebmeyer","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.yrtph.2026.106085_bib21","series-title":"Report on the European Chemicals Agency's \u201cNew Approach Methodologies Workshop: towards an Animal Free Regulatory System for Industrial Chemicals","year":"2023"},{"issue":"1","key":"10.1016\/j.yrtph.2026.106085_bib22","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s13321-017-0225-z","article-title":"An algorithm to identify functional groups in organic molecules","volume":"9","author":"Ertl","year":"2017","journal-title":"J. Cheminf."},{"issue":"35","key":"10.1016\/j.yrtph.2026.106085_bib23","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1021\/cen-v087n035.p011","article-title":"Chemicals leach from packaging","volume":"87","author":"Everts","year":"2009","journal-title":"Chem. Eng. News"},{"issue":"21","key":"10.1016\/j.yrtph.2026.106085_bib24","doi-asserted-by":"crossref","first-page":"4685","DOI":"10.1016\/j.febslet.2005.07.039","article-title":"CO: a chemical ontology for identification of functional groups and semantic comparison of small molecules","volume":"579","author":"Feldman","year":"2005","journal-title":"FEBS Lett."},{"issue":"1","key":"10.1016\/j.yrtph.2026.106085_bib83","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1093\/toxsci\/kfz201","article-title":"Utility of In vitro bioactivity as a lower bound estimate of in vivo adverse effect levels and in risk-based prioritization","volume":"173","author":"Paul Friedman","year":"2020","journal-title":"Toxicol Sci."},{"key":"10.1016\/j.yrtph.2026.106085_bib26","doi-asserted-by":"crossref","DOI":"10.3389\/ftox.2024.1431790","article-title":"New approach methodologies (NAMs) for the in vitro assessment of cleaning products for respiratory irritation: workshop report","volume":"6","author":"Haber","year":"2024","journal-title":"Front. Toxicol."},{"key":"10.1016\/j.yrtph.2026.106085_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.impact.2024.100523","article-title":"Next generation risk assessment approaches for advanced nanomaterials: current status and future perspectives","volume":"35","author":"Hristozov","year":"2024","journal-title":"NanoImpact"},{"key":"10.1016\/j.yrtph.2026.106085_bib29","series-title":"Report for the International Cooperation on Cosmetics Regulation Joint regulators-industry Working Group: Integrated Strategies for Safety Assessments of Cosmetic Ingredients - Part I","year":"2017"},{"key":"10.1016\/j.yrtph.2026.106085_bib30","series-title":"Report for the International Cooperation on Cosmetics Regulation Joint regulators-industry Working Group: Integrated Strategies for Safety Assessment of Cosmetic Ingredients: Part II","year":"2018"},{"key":"10.1016\/j.yrtph.2026.106085_bib31","series-title":"M7(R2). Assessment and Control of DNA Reactive (Mutagenic) Impurities in Pharmaceuticals to Limit Potential Carcinogenic Risk","year":"2023"},{"key":"10.1016\/j.yrtph.2026.106085_bib32","series-title":"Guideline for Extractables and Leachables. Q3E. Draft Version Endorsed on 01 August 2025","year":"2025"},{"issue":"19","key":"10.1016\/j.yrtph.2026.106085_bib33","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1002\/bdr2.2001","article-title":"A novel human stem cell-based biomarker assay for in vitro assessment of developmental toxicity","volume":"114","author":"Jamalpoor","year":"2022","journal-title":"Birth Defects Res"},{"issue":"6","key":"10.1016\/j.yrtph.2026.106085_bib34","first-page":"527","article-title":"Application of quality by design (QbD) principles to extractables\/leachables assessment. Establishing a design space for terminally sterilized aqueous drug products stored in a plastic packaging system","volume":"64","author":"Jenke","year":"2010","journal-title":"PDA J. Pharm. Sci. Technol."},{"issue":"2\u20134","key":"10.1016\/j.yrtph.2026.106085_bib36","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1080\/10937404.2010.483176","article-title":"Toxicity testing in the 21st century: a vision and a strategy","volume":"13","author":"Krewski","year":"2010","journal-title":"J. Toxicol. Environ. Health, Part B"},{"issue":"8","key":"10.1016\/j.yrtph.2026.106085_bib37","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1289\/ehp.1307260","article-title":"A framework for the next generation of risk science","volume":"122","author":"Krewski","year":"2014","journal-title":"Environ. Health Perspect."},{"issue":"1","key":"10.1016\/j.yrtph.2026.106085_bib38","first-page":"158","article-title":"An alternative safety profiling algorithm (ASPA) to transform next generation risk assessment into a structured and transparent process","volume":"43","author":"Leist","year":"2026","journal-title":"ALTEX"},{"key":"10.1016\/j.yrtph.2026.106085_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.tox.2025.154211","article-title":"Next generation risk assessment and new approach methodologies for safe and sustainable by design chemicals and materials: perspectives and challenges for occupational health","volume":"517","author":"Leso","year":"2025","journal-title":"Toxicol"},{"issue":"2","key":"10.1016\/j.yrtph.2026.106085_bib40","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1093\/toxsci\/kfaa035","article-title":"Development and application of TK6-derived cells expressing human cytochrome P450s for genotoxicity testing","volume":"175","author":"Li","year":"2020","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.yrtph.2026.106085_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.tiv.2021.105171","article-title":"Next generation risk assessment (NGRA): bridging in vitro points-of-departure to human safety assessment using physiologically-based kinetic (PBK) modelling - a case study of doxorubicin with dose metrics considerations","volume":"74","author":"Li","year":"2021","journal-title":"Toxicol. Vitro"},{"key":"10.1016\/j.yrtph.2026.106085_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2024.105715","article-title":"Safety assessment of drug impurities for patient safety: a comprehensive review","volume":"153","author":"Liu","year":"2024","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2026.106085_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2023.105335","article-title":"Semiquantitative sensitization safety assessment of extractable and leachables associated with parenteral pharmaceutical products","volume":"138","author":"Liu","year":"2023","journal-title":"Regul. Toxicol. Pharmacol."},{"issue":"2","key":"10.1016\/j.yrtph.2026.106085_bib44","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1093\/toxsci\/kfad012","article-title":"A pragmatic framework for the application of new approach methodologies in one health toxicological risk assessment","volume":"192","author":"Magurany","year":"2023","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.yrtph.2026.106085_bib45","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/s00204-022-03435-7","article-title":"A walk in the PARC: developing and implementing 21st century chemical risk assessment in Europe","volume":"97","author":"Marx-Stoelting","year":"2023","journal-title":"Arch. Toxicol."},{"issue":"1","key":"10.1016\/j.yrtph.2026.106085_bib46","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1093\/toxsci\/kfac068","article-title":"Are non-animal systemic safety assessments protective? A toolbox and workflow","volume":"189","author":"Middleton","year":"2022","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.yrtph.2026.106085_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.tiv.2019.104746","article-title":"Application of physiologically based kinetic (PBK) modelling in the next generation risk assessment of dermally applied consumer products","volume":"63","author":"Moxon","year":"2020","journal-title":"Toxicol. Vitro"},{"key":"10.1016\/j.yrtph.2026.106085_bib48","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1421601","article-title":"Next-generation risk assessment read-across case study: application of a 10-step framework to derive a safe concentration of daidzein in a body lotion","volume":"15","author":"Najjar","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.yrtph.2026.106085_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.tox.2024.153826","article-title":"A workflow to practically apply true dose considerations to in vitro testing for next generation risk assessment","volume":"505","author":"Nicol","year":"2024","journal-title":"Toxicol"},{"key":"10.1016\/j.yrtph.2026.106085_bib50","series-title":"Guidance on Grouping of Chemicals","year":"2014"},{"issue":"184","key":"10.1016\/j.yrtph.2026.106085_bib51","article-title":"Revised guidance document on developing and assessing adverse outcome pathways","year":"2017","journal-title":"Series on testing & assessment"},{"key":"10.1016\/j.yrtph.2026.106085_bib52","series-title":"Series on Testing & Assessment No. 349. ENV\/CBC\/MONO(2021)35","article-title":"Case study on the use of the use of integrated approaches for testing and assessment for the systemic toxicity of phenoxyethanol when included at 1% in a body lotion","year":"2021"},{"key":"10.1016\/j.yrtph.2026.106085_bib53","article-title":"Guidance document on the characterisation, validation and reporting of physiologically based kinetic (PBK) models for regulatory purposes","volume":"No. 331","year":"2021","journal-title":"OECD Series on Testing and Assessment"},{"key":"10.1016\/j.yrtph.2026.106085_bib54","article-title":"Case study on the use of integrated approaches for testing and assessment for skin sensitisation of diethanolamine: application of a next generation risk assessment framework. OECD series on testing and assessment, no. 331","year":"2023","journal-title":"OECD, 2025. Guideline No. 497. Defined approaches on skin sensitization"},{"issue":"3","key":"10.1016\/j.yrtph.2026.106085_bib56","first-page":"419","article-title":"Next-generation risk assessment of chemicals - rolling out a human-centric testing strategy to drive 3R implementation: the RISK-HUNT3R project perspective","volume":"39","author":"Pallocca","year":"2022","journal-title":"ALTEX"},{"key":"10.1016\/j.yrtph.2026.106085_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2025.105776","article-title":"Comprehensive extractables and leachables sensitization analysis and practical application of a risk-based approach to sensitization assessment for parenteral drug products","volume":"157","author":"Parris","year":"2025","journal-title":"Regul. Toxicol. Pharmacol."},{"issue":"5","key":"10.1016\/j.yrtph.2026.106085_bib58","doi-asserted-by":"crossref","first-page":"430","DOI":"10.5731\/pdajpst.2013.00936","article-title":"The product quality research institute (PQRI) leachables and extractables WG initiative for parenteral and ophthalmic drug product (PODP)","volume":"67","author":"Paskiet","year":"2013","journal-title":"PDA J. Pharm. Sci. Technol."},{"key":"10.1016\/j.yrtph.2026.106085_bib80","doi-asserted-by":"crossref","first-page":"838466","DOI":"10.3389\/ftox.2022.838466","article-title":"Beyond AOPs: a mechanistic evaluation of NAMs in DART testing","volume":"4","author":"Rajagopal","year":"2022","journal-title":"Front Toxicol"},{"key":"10.1016\/j.yrtph.2026.106085_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.mrgentox.2025.503878","article-title":"Comparison of different techniques for \u03b3H2AX\/pH3 biomarkers quantification for chemical genotoxicity assessment","volume":"906","author":"Recoules","year":"2025","journal-title":"Mutat. Res., Genet. Toxicol. Environ. Mutagen."},{"key":"10.1016\/j.yrtph.2026.106085_bib60","volume":"vol. 436","author":"Rogiers","year":"2020"},{"key":"10.1016\/j.yrtph.2026.106085_bib61","first-page":"883","article-title":"Systems biology application in toxicology: steps toward next generation risk assessment in regulatory toxicology","volume":"vol. 8","author":"Scanlan","year":"2024"},{"key":"10.1016\/j.yrtph.2026.106085_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.envint.2023.108082","article-title":"New approach methodologies in human regulatory toxicology - not if, but how and when","volume":"178","author":"Schmeisser","year":"2023","journal-title":"Environ. Int."},{"key":"10.1016\/j.yrtph.2026.106085_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.yrtph.2025.105794","article-title":"Next generation risk assessment of hair dye HC yellow no. 13: ensuring protection from liver steatogenic effects","volume":"159","author":"Sepehri","year":"2025","journal-title":"Regul. Toxicol. Pharmacol."},{"issue":"4","key":"10.1016\/j.yrtph.2026.106085_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2025.104328","article-title":"Opportunities and insights from pharmaceutical companies on the current use of new approach methodologies in nonclinical safety assessment","volume":"30","author":"Shenton","year":"2025","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.yrtph.2026.106085_bib82","doi-asserted-by":"crossref","first-page":"113212","DOI":"10.1016\/j.fct.2022.113212","article-title":"Use of transcriptomics in hazard identification and next generation risk assessment: A case study with clothianidin","volume":"166","author":"Sprenger","year":"2022","journal-title":"Food Chem Toxicol"},{"key":"10.1016\/j.yrtph.2026.106085_bib67","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1038\/s41551-023-01154-7","article-title":"Towards in vitro models for reducing or replacing the use of animals in drug testing","volume":"8","author":"Stresser","year":"2024","journal-title":"Nat. Biomed. Eng."},{"issue":"2","key":"10.1016\/j.yrtph.2026.106085_bib68","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1208\/s12249-014-0221-9","article-title":"A risk-based approach to management of leachables utilizing statistical analysis of extractables","volume":"16","author":"Stults","year":"2015","journal-title":"AAPS PharmSciTech"},{"issue":"1","key":"10.1016\/j.yrtph.2026.106085_bib69","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1021\/acs.analchem.8b05293","article-title":"Recent advances in Body-on-a-Chip systems","volume":"91","author":"Sung","year":"2019","journal-title":"Anal. Chem."},{"issue":"2","key":"10.1016\/j.yrtph.2026.106085_bib70","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1093\/toxsci\/kfz058","article-title":"The next generation blueprint of computational toxicology at the U.S. environmental protection agency","volume":"169","author":"Thomas","year":"2019","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.yrtph.2026.106085_bib72","series-title":"Guidance for Industry, Container Closure Systems for Packaging Human Drugs and Biologics","year":"1999"},{"key":"10.1016\/j.yrtph.2026.106085_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.namjnl.2025.100020","article-title":"Highlighting best practices to advance next-generation risk assessment of cosmetic ingredients","volume":"1","author":"Vaillancourt","year":"2025","journal-title":"NAM J"},{"issue":"11","key":"10.1016\/j.yrtph.2026.106085_bib74","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1007\/s00204-022-03365-4","article-title":"A framework for establishing scientific confidence in new approach methodologies","volume":"96","author":"van der Zalm","year":"2022","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.yrtph.2026.106085_bib75","article-title":"Next generation risk assessment of human exposure to anti-androgens using newly defined comparator compound values","volume":"73","author":"van","year":"2021","journal-title":"Toxicol. Vitro"},{"issue":"1","key":"10.1016\/j.yrtph.2026.106085_bib77","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1021\/acs.chemrestox.9b00264","article-title":"Predicting drug-induced liver injury with bayesian machine learning","volume":"33","author":"Williams","year":"2020","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.yrtph.2026.106085_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/j.tox.2024.153835","article-title":"Next generation risk assessment for occupational chemical safety \u2013 a real world example with sodium-2-hydroxyethane sulfonate","volume":"506","author":"Wood","year":"2024","journal-title":"Toxicol"}],"container-title":["Regulatory Toxicology and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230026000589?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230026000589?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T16:56:23Z","timestamp":1778086583000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0273230026000589"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":73,"alternative-id":["S0273230026000589"],"URL":"https:\/\/doi.org\/10.1016\/j.yrtph.2026.106085","relation":{},"ISSN":["0273-2300"],"issn-type":[{"value":"0273-2300","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"10-step systemic safety assessment of extractables and leachables associated with drug products integrating topline, traditional, and next generation risk assessment","name":"articletitle","label":"Article Title"},{"value":"Regulatory Toxicology and Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yrtph.2026.106085","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106085"}}